0 Évaluations
ID

22184

Description

A Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Rosiglitazone (Extended Release Tablets) on Cerebral Glucose Utilization and Cognition in Subjects With Mild to Moderate Alzheimer's Disease (AD) Medicine: rosiglitazone, Condition: Alzheimer's Disease, Phase: 2, Clinical Study ID: 49653/461, Sponsor: GSK Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Lien

https://clinicaltrials.gov/ct2/show/NCT00265148?term=NCT00265148&rank=1

Mots-clés

Versions (1)
  1. 22/05/2017 22/05/2017 -
Téléchargé le

22 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

    Anglais

    Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

    1 Formulaires  
    Prior Medication
    Description

    Prior Medication

    Alias
    UMLS CUI-1
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
    Description

    Pharmaceutical preparations

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    If ´YES`, please record the medications below.
    Description

    specification

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    UMLS CUI [1,2]
    C2348235 (Specification)
    Prior Medication
    Description

    Prior Medication

    Alias
    UMLS CUI-1
    C2826257 (Prior Medication Usage)
    Drug name (Trade Name preferred)
    Description

    Drug name

    Type de données

    text

    Alias
    UMLS CUI [1]
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    Single Dose/ Unit (e.g. 500mg)
    Description

    Single dose/Unit

    Type de données

    float

    Unités de mesure
    • mg
    Alias
    UMLS CUI [1,1]
    C2826257 (Prior Medication Usage)
    UMLS CUI [1,2]
    C1960417 (Single dose characteristic)
    SNOMED
    426146003
    mg
    Frequency of this Dose (e.g. BID PRN)
    Description

    Frequency

    Type de données

    text

    Alias
    UMLS CUI [1]
    C3476109 (Medication frequency)
    LOINC
    LP149758-7
    Route
    Description

    Route

    Type de données

    text

    Alias
    UMLS CUI [1]
    C0013153 (Drug Administration Routes)
    SNOMED
    410675002
    LOINC
    LP40261-7
    Indication
    Description

    Indication

    Type de données

    text

    Alias
    UMLS CUI [1,1]
    C3146298 (Indication)
    UMLS CUI [1,2]
    C0013227 (Pharmaceutical Preparations)
    SNOMED
    763158003
    LOINC
    LP100609-9
    End Date
    Description

    End Date

    Type de données

    date

    Unités de mesure
    • Day Month Year
    Alias
    UMLS CUI [1]
    C1531784 (Date treatment stopped)
    SNOMED
    413947000
    Day Month Year
    Continuing at end of
    Description

    Continuing

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111 (Therapeutic procedure)
    SNOMED
    277132007
    LOINC
    LP21090-3
    UMLS CUI [1,2]
    C1553904 (continuing therapy)
    Retour au début de la page

    Similar models

    Prior Medication Effects of Rosiglitazone on Cerebral Glucose Utilization and Cognition in Subjects With Alzheimer's Disease NCT00265148

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    Prior Medication
    C0013227 (UMLS CUI-1)
    Pharmaceutical preparations
    Item
    Has the patient taken any medication within 1 week PRIOR to the first dose of study medication?
    boolean
    C0013227 (UMLS CUI [1])
    specification
    Item
    If ´YES`, please record the medications below.
    text
    C0013227 (UMLS CUI [1,1])
    C2348235 (UMLS CUI [1,2])
    Item Group
    Prior Medication
    C2826257 (UMLS CUI-1)
    Drug name
    Item
    Drug name (Trade Name preferred)
    text
    C0013227 (UMLS CUI [1])
    Single dose/Unit
    Item
    Single Dose/ Unit (e.g. 500mg)
    float
    C2826257 (UMLS CUI [1,1])
    C1960417 (UMLS CUI [1,2])
    Frequency
    Item
    Frequency of this Dose (e.g. BID PRN)
    text
    C3476109 (UMLS CUI [1])
    Route
    Item
    Route
    text
    C0013153 (UMLS CUI [1])
    Indication
    Item
    Indication
    text
    C3146298 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    End Date
    Item
    End Date
    date
    C1531784 (UMLS CUI [1])
    Continuing
    Item
    Continuing at end of
    boolean
    C0087111 (UMLS CUI [1,1])
    C1553904 (UMLS CUI [1,2])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial